Shanghai Sunway Biotech
China - ShanghaiBiotechnology
Focus: Shanghai Sunway Biotech is a China-based biologics company focused on infectious disease therapeutics, currently advancing fixed-dose combination antiretroviral products. The company operates as a mid-to-late stage biotech with pre-launch stage assets in the HIV treatment space.
Profile data last refreshed 17h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Shanghai Sunway Biotech
AI assessmentNot HiringNo open roles listed right now. Follow Shanghai Sunway Biotech to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Pre-Launch
Fixed-dose combination integrase inhibitor (dolutegravir) plus two nucleoside reversetranscriptase inhibitors; represents three-in-one simplification strategy for HIV treatment.
Help build intelligence for Shanghai Sunway Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.